Figure skater Michelle Hong used to hide her skin as much as possible due to her condition—but with effective treatment and ...

Apogee Therapeutics’ anti-IL-13 antibody has been tied to a 71% reduction in eczema severity after 16 weeks, hitting the main ...

Nektar Therapeutics (NASDAQ:NKTR) is one of the best hot stocks to buy according to Wall Street analysts. On June 24, Nektar ...

In this video, Jeff Yu, MD, MS, emphasized the importance of chronic hand eczema awareness and highlighted a study on the causes and treatments of the disease, presented at the Revolutionizing Atopic ...

When Rachel Evans developed a rash that made her feel as though she had 'insects crawling all over her body', doctors ...

When a mysterious rash spread across Rachel Evans’ body, doctors kept telling her it was just eczema. But Rachel, 46, knew ...

In this video, Robert J. Smith, MD, discusses the many treatment options available to patients with atopic dermatitis.

Rezpegaldesleukin (Rezpeg) shows fast, effective eczema relief in Phase 2 trial with fewer side effects than other treatments, offering hope for moderate-to-severe cases.

Your hands and feet are especially vulnerable to eczema triggers like dry winter air or heat in summer. WebMD gives you tips on preventing your eczema from flaring up.

A genetically-induced skin disease, commonest in boys and women shall be the centrepiece campaign of dermatologists in the ...

Apogee Therapeutics said its antibody treatment alleviated signs and symptoms of atopic dermatitis far more than a placebo — ...

Nektar Therapeutics shares doubled in early trading Tuesday after the U.S. biotech firm said it reached its targets in a ...